The B1 receptors for kinins

Pharmacological Reviews

Volumn 50, Issue 3, 1998, Pages 357-386

  Marceau, François ^a   Hess, J Fred ^b   Bachvarov, Dimcho R ^a  

^a LAVAL UNIVERSITY   (Canada)

^b MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRADYKININ ANTAGONIST; BRADYKININ RECEPTOR AGONIST; KININ; RECEPTOR SUBTYPE; BRADYKININ; BRADYKININ B1 RECEPTOR; BRADYKININ B2 RECEPTOR; BRADYKININ RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN;

AMINO ACID SEQUENCE; CIRCULATION; FEVER; FIBROSIS; HUMAN; INFLAMMATION; KALLIKREIN KININ SYSTEM; PAIN; PRIORITY JOURNAL; RECEPTOR AFFINITY; REVIEW; ANIMAL; CLASSIFICATION; DRUG ANTAGONISM; DRUG EFFECT; DRUG POTENTIATION; GENETIC POLYMORPHISM; GENETIC TRANSCRIPTION; GENETICS; METABOLISM; MOLECULAR GENETICS; PHYSIOLOGY; UPREGULATION;

AMINO ACID SEQUENCE; ANIMALS; BRADYKININ; GTP-BINDING PROTEINS; HUMANS; KALLIKREIN-KININ SYSTEM; MOLECULAR SEQUENCE DATA; POLYMORPHISM, GENETIC; RECEPTOR, BRADYKININ B1; RECEPTOR, BRADYKININ B2; RECEPTORS, BRADYKININ; TRANSCRIPTION, GENETIC; UP-REGULATION;

EID: 0031595552     PISSN: 00316997     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (236)

1. Abbas F, Clayton JK, Marshall KM and Senior J (1998) Characterization of kinin receptors on the human isolated umbilical artery. J Endocrinol 156:389-394.
2. 1 receptors in the polymorphonuclear leukocyte accumulation induced by IL-1β in vivo in the mouse, J Immunol 156:269-274.
3. Alfie ME, Yang XP, Hess F and Carretero OA (1996) Salt-sensitive hypertension in bradykinin B2 receptor knockout mice, Biochem Biophys Res Commun 224:625-630.
4. 2 receptors in the mouse. Can J Physiol Pharmacol 73:1759-1764.
5. 9-bradykinin, on rat croton oil-induced granulation tissue contraction. Br J Pharmacol 111:290P.
6. Aramori I, Zenkoh J, Morikawa N, O'Donnell N, Asano M, Nakamura K, Iwami M, Kojo H and Notsu Y (1997) Novel subtype-selective nonpeptide bradykinin receptor antagonists FR167344 and FR173657. Mol Pharmacol 51:171-176.
7. 2 receptor antagonist, FR 167344, on different in vivo animals models of inflammation. Br J Pharmacol 122:1436-1440.
8. 2-receptor gene. Br J Pharmacol 117:196P.
9. 1 receptors in isolated rabbit aorta by using metabolic inhibitors. Eur J Pharmacol 271:551-555.
10. 1 receptor for kinins, in the anesthetized rabbit pretreated with a sublethal dose of bacterial lipopolysaccharide. J Pharmacol Exp Ther 280:6-15.
11. Austin KE, Faussner A, Robinson HE, Chakravarty S, Kyle DJ, Bathon JM and Proud D (1997) Stable expression of the human kinin Bl receptor in Chinese hamster ovary cells. J Biol Chem 272:11420-11425.
12. 1 receptor gene for kinins (BDKRB1). Genomics 33:374-381
13. 1 receptor gene in inflammatory bowel disease. Gastroenterology, in press.
14. 1 receptor gene: Altered frequency of an allele in patients with a history of end stage renal failure. J Am Soc Nephrol 9:598-604.
15. 2 receptor. J Pharmacol Exp Ther 275:1623-1630.
16. 1 receptor [abstract], Hypertension 30:998.
17. Bascands JL, Pecher C, Rouaud S, Emond C, Leung Tack J, Bastie MJ, Burch R,. Regoli D and Girolami JP (1993) Evidence for existence of two distinct bradykinia receptors on rat mesangial cells. Am J Physiol 264:F548-F556.
18. 1 receptor in 293 cells: Pharmacological and functional characterization. Br J Pharmacol 122:393-399.
19. Bathon JM, Manning DC, Goldman DW, Towns MC and Proud D (1992) Characterization of kinin receptors on human synovial cells and upregulation of receptor number by interieukin-1. J Pharmacol Exp Ther 260:384-392.
20. Beasley D, Cohen RA and Levinsky NG (1991) Interleukin 1 inhibits contraction of vascular smooth muscle. J Clin Invest 83:331-335.
21. 2 receptor stimulation in conscious instrumented dogs. Br J Pharmacol 117:1565-1571.
22. Ben Nasr A. Herwall H, Sjöbring U, Renné T, Müller-Esterl W and Björck L (1997) Absorption of kininogen from human plasma by Streptococcus pyogenes is followed by the release of bradykinin. Biochem J 326:657-660.
23. Berry TD, Hasstedt SJ, Hunt SC, Wu LL, Smith JB, Ash KO, Kuida H and Williams RR (1989) A gene for high urinary kailikrein may protect against hypertension in Utah kindreds. Hypertension 13:3-8.
24. Bhoola R, Ramsaroop R, Naidoo S, Müller-Esterl W and Bhoola KD (1997) Kinin receptor status in normal and inflamed gastric mucosa. Immunopharmacolagy 36:161-165.
25. 2+ in aortic vascular smooth muscle cells. Can J Physiol Pharmacol 75:652-660.
26. Biais C Jr, Couture R, Drapeau G, Colman RW and Adam A (1997a) Involvement of endogenous kinins in the pathogenesis of peptidoglycan-induced arthritis in the Lewis rat. Arthritis Rheum 40:1327-1333.
27. Biais C Jr., Drapeau G, Raymond P, Lamontagne D, Gervais N, Venneman I and Adam A (1997b) Contribution of angiotensin-converting enzyme to the cardiac metabolism of bradykinin: An interspecies study. Am J Physiol 273:H2263-H2271.
28. 2 bradykinin receptor gene in mice eliminates bradykinin action in smooth muscle and neurons. J Biol Chem 270:13706-13710.
29. Bouchard JF, Chouinard J and Lamontagne D (1998) Role of kinins in the endothelial protective effect of ischaemic preconditioning. Br J Pharmacol 123: 413-420.
30. 9-bradykinin in vitro and in vivo. Br J Pharmacol 92:257-264.
31. Burch RM and DeHaas C (1990) A bradykinin antagonist inhibits carrageenan edema in rats. Naunyn-Schmiedeberg Arch Pharmacol 342:189-193.
32. 2 receptors. Immunopharmacology 33:186-190.
33. 1 receptors in the rabbit urinary bladder: Induction of responses, smooth muscle contraction and phospha- tidylinositol hydrolysis. Br J Pharmacol 114:612-617.
34. 9-bradykinin-induced contraction in the guinea-pig gallbladder in vitro. Eur J Pharmacol 331:31-38.
35. Campbell CA, Mackay KB, Hadingham SJ, King PD, Patel SR and Hamilton TC (1997) SB-238592 (CP-0127) does not reduce indices of ischaemic damage following permanent or transient focal cerebral ischaemia in normotensive rats. Br J Pharmacol 122:324P.
36. 2 receptors. J Pharmacol Exp Ther 268:902-909.
37. 2 kinin receptors in oedema formation after long-term treatment with mycobacterium bovis bacillus Calmette-Guérin (BCG). Br J Pharmacol 120:502-508.
38. 1 kinin receptors mediating paw edema and formalin-induced nociception: Modulation by glucocorticoids. Can J Physiol Pharmacol 73:812-819.
39. 9- BK-induced rat paw oedema by systemic treatment with bacterial endotoxin. Br J Pharmacol 117:793-798.
40. 2 receptors in human PMN elastase release and increase in endothelial cell monolayer permeability. Immunopharmacology 33:325-329.
41. 1 receptor. Br J Pharmacol 108:318-322.
42. Chai KX, Chen LM, Chao J and Chao L (1993) Kallistatin: A novel human serine proteinase inhibitor-Molecular cloning, tissue distribution and expression in Escherichia coli. J Biol Chem (Tokyo) 268:24498-24505.
43. 1 bradykinin receptor gene BDKRB1. Genomics 31:51-57.
44. Chen LM, Richards GP, Chao L and Chao J (1995a) Molecular cloning, purification and in situ localization of human colon kailikrein. Biochem J 307:481-486.
45. Chen LM, Song Q, Chao L and Chao J (1995b) Cellular localization of tissue kailikrein and kallistatin mRNAs in human kidney. Kidney Int 48:690-697.
46. Chung DW, Fujikawa K, McMullen BA and Davie EW (1986) Human plasma pre- kallikrein, a zymogen to a serine protease that contains four tandem repeats, Biochemistry 25:2410-2417.
47. 1 kinin receptor-mediated vascular relaxation to contraction. Hypertension 9:1-5.
48. 2 receptors in the febrile response induced by endotoxin in rate. Br J Pharmacol 121:296-302.
49. Couture R, Mizrahi J, Regoli D and Devroede G (1981) Peptides and the human colon: An in vitro pharmacological study. Can J Physiol Pharmacol 59:957-964.
50. 1 receptors in the maintenance of intra-articular plasma extravasation in chronic antigen-induced arthritis. Br J Pharmacol 113:940-944.
51. Gumming AD, Walsh T, Wojtacha D, Fleming S, Thomson D and Jenkins DA (1994) Expression of tissue kailikrein in human kidney. Clin Sci (Colch) 87:5-11.
52. Cuthbert A, Huxley C and Hess JF (1996) Removal and restoration of epithelial chloride secretory activity of kinins by gene manipulation. Immunopharmacology 33:217-221.
53. Cuthbert AW, Kirkl SC and McVinish LJ (1985) Kinin effects on ion transport in monolayers of HCA-7 cells, a line from a human colonic adenocarcinoma. Br J Pharmacol 86:3-5.
54. Davies MG and Hagen PO (1994) Bradykinin receptor modulation in vein grafts. J Invest Surg 7:493-501.
55. Davis AJ and Perkins MN (1994a) Induction of B1 receptors in vivo in a model of persistent inflammatory mechanical hyperalgesia in the rat Neuropharmacology 33:127-133.
56. 2 receptor mechanisms in cytokine-induced mechanical hyperalgesia in the rat. Br J Pharmacol 113:63-68.
57. Davis AJ and Perkins MN (1996) Substance P and capsaicin-induced mechanical hyperalgesia in the rat knee joint: the involvement of bradykinin Bl and B2 receptors. Br J Pharmacol 118:2206-2212.
58. 9-BK-induced mechanical hyperalgesia and analgesia in the rat: Involvement of IL-1, prostaglandins and peripheral opioids. Br J Pharmacol 120:74P.
59. 1 bradykinin receptors and sensory neurons. Br J Pharmacol 118:1469-1476.
60. 9-brady kinin. Br J Pharmacol 93:969-977.
61. 9-bradykinin: Possible role of interleukin-1. Br J Pharmacol 103:1057-1066.
62. 9-bradykinin or of α-thrombin in rabbit aortic rings. Br J Pharmacol 105:959-967.
63. 9]BK in carrageenan-induced edema. Peptides 17: 1009-1015.
64. Décarie A, Drapeau G, Closset J, Couture R and Adam A (1994) Development of digoxigenin-labeled peptide: Application to chemiluminoenzyme immunoassay of bradykinin in inflamed tissues. Peptides 15:511-518.
65. 9]BK: Influence of enalaprilat Am J Physiol 270:H1340-H1347.
66. De Kimpe SJ, Tielemans W, Van Heuven-Nolsen D and Nijkamp FP (1994) Reversal of bradykinin-induced relaxation to contraction after interferon-γ in bovine isolated mesenteric arteries. Ear J Pharmacol 261:111-120.
67. Deperthes D, Marceau F, Frenette G, Lazure C, Tremblay RR and Dubé JY (1997) Human kallikrein hK2 has low kininogenase activity while prostate-specific antigen (hK3) has none. Biochim Biophys Acta 1343:102-106.
68. 1 MF-2 smooth muscle cells. J Biol Chem 272:17858-17866.
69. 1 receptor-mediated responses in the pulmonary vascular bed Cire Res 75:1064-1072.
70. Dixon BS (1994) Cyclic AMP selectively enhances bradykinin receptor synthesis and expression in cultured arterial smooth muscle: Inhibition of angiotensin II and vasopressin response. J Clin Invest 93:2535-2544.
71. Dixon BS and Dennis MJ (1997) Regulation of mutagenesis by kinins in arterial smooth muscle cells. Am J Physiol 273:C7-C20.
72. 2 receptor is a delayed early response gene for platelet-derived growth factor in arterial smooth muscle cells. J Biol Chem 271:13324-13332.
73. 1 receptors for kinins. J Pharmacol Exp Ther 266:192-199.
74. Drapeau G, Chow A and Ward PE (1991a) Metabolism of bradykinin agonists and antagonists by angiotensin I converting enzyme and carboxypeptidase N. Peptides 12:631-638.
75. 1 receptors for kinins. J Pkar- macol Exp Ther 259:997-1003.
76. Dray A, Bettaney J, Forster P and Perkins MN (1988) Activation of a bradykinin receptor in peripheral and spinal cord in the neonatal rat in vitro. Br J Pharmacol 95:1008-1010.
77. 2 kinin receptors in the bovine isolated coronary artery. Br J Pharmacol 116:2473-2481.
78. 9bradykinin in human coronary arteries. Br J Pharmacol 116:3083-3085.
79. Elliot DF, Horton EW and Lewis GP (1960) Actions of pure bradykinin. J Physiol (Land.) 153:473-480.
80. Erdbs EG (1990) Some old and some new ideas on kinin metabolism. J Cardiovasc Pharmacol 15(Suppl 6):S20-S24.
81. Erdös EG and Miwa I (1968) Effect of endotoxin shock on the plasma kallikrein-kinin system of the rabbit Fed Proc 27:92-95.
82. 1 receptors in vivo during antigen arthritis. Agents Actions 34:191-193.
83. Fathy DB, Mathis A, Leeb T and Leeb-Lundberg LMF (1997) The third transmembrane domains of the human Bl and B2 bradykinin receptor subtypes are involved in discriminating between subtype-selective liganda [abstract]. FASEB J 11: A1328.
84. Faussner A, Proud D, Towns M and Bathon J (1996) Influence of the cytosolic carfooxy termini of Bl and B2 kinin receptors on ligand internalization. Presented at die International Multidisciplinary Symposium on Peptide Receptors, Montreal, Canada, July 28-August 1.
85. Fein AM, Bernard GR, Criner GJ, Fletcher EC, Good JT, Knaus WA, Levy H, Matuschak GM, Shanies HM, Taylor RW and Rodeil TC (1997) Treatment of severe systemic inflammatory response syndrome and sepsis with a novel brady-kinin antagonist, deltibant (CP-0127): Results of a randomized, double-blind, placebo-controlled trial. J Am Med Assoc 277:482-487.
86. 2 receptor involvement in rabbit and murine models of septic shock. J Cardiovasc Pharmacol 27:500-507.
87. Feng J, Yamaguchi N, Foucart S, Chahine R, Lamontagne D and Nadeau R (1997) Transient ischemia inhibits nonexocytotic release of norepinephrine following sustained ischemia in rat heart: Is bradykinin involved? Can J Physiol Pharmacol 75:665-670.
88. Fenoy FJ and Roman RJ (1992) Effect of kinin receptor antagonists on renal hemodynamic and natriuretic responses to volume expansion. Am J Physiol 263: R1136-R1140.
89. 2 kinin receptors during metabolic anoxia in the rat isolated atria. Can J Physiol Pharmacol 75:639-645.
90. Fukushima D, Kitamura N and Nakanishi S (1985) Nucleotide sequence of cloned cDNA for human pancreatic kallikrein. Biochemistry 24:8037-8043.
91. 2 production. Br J Pharmacol 113:389-394.
92. Gebhard W, Schuhe M and Eulitz M (1989) cDNA cloning and complete primary structure of the small, active subunit of human carboxypeptidase N (kininase 1). Eur J Biochem 178:603-607.
93. Gera L, Stewart JM, Whalley ET, Burkard M and Zuzack JS (1996) New bradykinin antagonists having high potency at BX receptors. Immunopharmacology 33:183-185.
94. Ghebrehiwet B and Galanakis DK (1993) C1q inhibitor (chondroitin-4-suIfate proteoglycan): Structure and function, Behring Inst Mitt 93:214-223.
95. 1 receptor-related peptides. Antagonists. Hypertension 28:833-839.
96. 1 receptors. Can J Physiol Pharmacol 75:591-595.
97. Gobeil F, Pheng LH, Badini I, Nguyen-Le XK, Pizard A, Rizzi A, Blouin D and Regoli D (1996b) Receptors for kinin in the human isolated umbilical vein. Br J Pharmacol 118:289-294.
98. Goldstein RH and Fine A (1995) Potential therapeutic initiatives for fibrogenic lung diseases. Chest 108:848-855.
99. 9bradykinin. J Biol Chem 259:9263-9268.
100. Gouin L, Cardinal R, Adam A, Drapeau G and Nadeau R (1996) Kinin-induced prolongation of action-potential duration in right ventricular muscle from rat: Involvement of Bl and B2 receptors. J Cardiovasc Pharmacol 28:337-343.
101. Green PG, Jänig W and Levine JD (1997) Negative feedback neuroendocrine control of inflammatory response in the rat is dependent on the sympathetic postganglionic neuron. J Neurosci 17:3234-3238.
102. Hagiwara Y, Kojima M, Kuraishi T, Hagashi I, Miyata T and Oh-Ishi S (1995) Identification of rat urinary kinin as bradykinin- Life Sci 57:997-1002.
103. 2 bradykinin receptors. Mol Pharmacol 45: 1-8.
104. Hess JF, Borkowski JA, Young GS, Strader CD and Ransom RW (1992) Cloning and pharmacological characterization of a human bradykinin (BK-2) receptor. Biochem Biophys Res Comm 184:260-268.
105. 1 receptors. Immunopharmacology 33:1-8.
106. Hock FJ, Wirth KJ, Albus U, Linz W, Gerhards HJ, Wiemer G, Henke S, Breipohl G, König W, Knolle J and Schölkens BA (1991) Hoe 140 a new potent and long acting bradykinin-antagonist: In vitro studies. Br J Pharmacol 102:769-773.
107. Hsieh ML, Charlesworth MC, Goodmanson M, Zhang S, Seay T, Klee GG, Tindall DJ and Young CYF (1997) Expression of human prostate-specific glandular kallikrein protein (hK2) in the breast cancer cell line T47-D. Cancer Res 57:2651-2656.
108. Hyde RJ, Hooper NM and Turner AJ (1996) Molecular cloning and expression in COS-1 cells of pig kidney aminopeptidase P. Biochem J 319:197-201.
109. 2 receptor antagonists upon viscera-visceral hyper-reflexia in a rat model of visceral hyperalgesia. Pain 75: 169-176.
110. 9-bradykinin on ion transport across normal and inflamed rat colonie mucosa [abstract]. Gastroenterology 90:1481.
111. 2 receptor gene: Full length cDNA, genomic organization and identification of the regulatory region. Biochem Biophys Res Comm 211:226-233.
112. Kaplan AP, Joseph K, Shibayama Y, Reddigari S, Ghebrehiwet B and Silverberg M (1997) The intrinsic coagulation/kinin-forming cascade: Assembly in the plasma and cell surfaces in inflammation. Adv Immunol 66:225-272.
113. Khasar SG, Miao FJ and Levine JD (1995) Inflammation modulates the contribution of receptor-subtypes to bradykinin-induced hvperalgesia in the rat Neuroscience 69:685-690.
114. 1-receptor synthesis by heat stress in the rat. Br J Pharmacol 121:1045-1046.
115. 9-bradykinin release following reperfusion of the ischemic rat heart. Br J Pharmacol 115:476-478.
116. 1-receptor-induced hypotension in the anesthetized dog. J Cardiovasc Pharmacol 28:45-650.
117. 1 receptors induced by tissue injury. J Immunol 160:1419-1426.
118. Leeb T, Mathis SA and Leeb-Lundberg LMF (1997) The sixth transmembrane domains of the human Bl and B2 bradykinin receptors are structurally compatible and involved in discriminating between subtype-selective agonists. J Biol Chem 272:311-317.
119. Leslie FM (1987) Methods used for the study of opioid receptors. Pharmacol Rev 39:197-249.
120. 1 receptors and development of a cellular model for the investigation of these receptors. Br J Pharmacol 109:1254-1262.
121. 1 receptors for kinins. Immunopharmacology 29: 141-147.
122. Levesque L, Larrivée JF, Bachvarov DR, Rioux F, Drapeau G and Marceau F (1995b) Regulation of kinin-induced contraction and DNA synthesis by inflammatory cytokines in the smooth muscle of the rabbit aorta. Br J Pharmacol 116:1673-1679.
123. Linz W, Wiemer G, Gohlke P, Unger T and Schölkens BA (1995) Contribution of kinins to the cardiovascular actions of angiotensin-converting enzyme inhibitors. Pharmacol Rev 47:25-49.
124. Lommi J, Pulkki K, Koskinen P, Naveri H, Harkonen M and Kupari M (1997) Haemodynamic, neuroendocrine and metabolic correlates of circulating cytokine concentrations in congestive heart failure. Eur Heart J 18:1620-1625.
125. 2-kinin receptors in the renal tubular and hemodynamic response to bradykinin. Am J Physiol 262:R72-R76.
126. Lung CC, Chan EKL and Zuraw BL (1997) Analysis of an exon 1 polymorphism of the B2 bradykinin receptor gene and its transcript in normal subjects and patients with Cl inhibitor deficiency. J Allergy Clin Immunol 99:134-146.
127. 2 receptor. Genomics 23:362-369.
128. 1 receptor Biochim Biophys Acta 1264: 223-228.
129. 1 receptors. Can J Physiol Pharmacol 75:735-740.
130. 2-receptor expression by estrogen. Br J Pharmacol 121:1763-1769.
131. Majima M and Katori M (1995) Approaches to the development of novel antihypertensive drugs: Crucial role of the renal kallikrein-kinin system. Trends Pharmacol Sci 16:239-246.
132. Malfroy B, Kado-Fong H, Gros C, Giros B, Schwartz JC and Hellmiss R (1989) Molecular cloning and amino acid sequence of rat kidney aminopeptidase M: A member of a super family of zinc-metallohydrolases. Biochem Biophys Res Com. mun 161:236-241.
133. Manning DC, Snyder SH, Kachur JF, Miller RJ and Field M (1982) Bradykinin receptor-mediated chloride secretion in intestinal function. Nature (Lond.) 299: 256-259.
134. 1 receptors: A review. Immunopharmacology 30:1-26.
135. Marceau F (1997) Is there a role for bradykinin in the therapeutic and side effects of angiotensin-con verting enzyme inhibitors? Can J Cardiol 13:187-194.
136. Marceau F, Barabé J, St-Pierre S and Regoli D (1980) Kinin receptors in experimental inflammation. Can J Physiol Pharmacol 58:536-542.
137. 9-BK in plasma. Can J Physiol Pharmacol 59:131-138.
138. 1 receptor: An inducible G protein coupled receptor. Can J Physiol Pharmacol 75:725-730.
139. Marceau F and Regoli D (1991) Kinin receptors of the Bl type and their antagonists, in Bradykinin Antagonists (Burch RM ed) pp 33-49, Marcel Dekker, New York.
140. Margolius HS (1995) Kallikreins and kinins: Some unanswered questions about system characteristics and roles in human disease. Hypertension 26:221-229.
141. 9-bradykinin-induced increases in intracellular calcium ion concentration in single bovine tracheal smooth muscle cells. Br J Pharmacol 112:934-938.
142. 2+ signaling in single cultured vascular smooth muscle cells. Mol Pharmacol 50:128-139.
143. 2 bradykinin receptor. Proc Natl Acad Sci USA 88:7724-7728.
144. McFadden RG and Vickers KE (1989) Bradykinin augments the in vitro migration of nonsensitized lymphocytes. Clin Invest Med 12:247-253.
145. 2 pharmacological selectivity. Mol Pharmacol 44:346-355.
146. 1 receptors. Br J Pharmacol 117: 1619-1624.
147. 1 bradykinin receptor. J Biol Chem 269:21583-21586.
148. Murata T, Ushikubi F, Matsuoka T, Hirata M, Yamasaki A, Sugimoto Y, Ichikawa A, Aze Y, Tanaka T, Yoshida N, Ueno A, Qh-Ishi S and Narumiya S (1997) Altered pain perception and inflammatory response in mice lacking prostacyclin receptor Nature (Lortd.) 388:678-682.
149. Naclerio RM, Proud D, Lichtenstein LM, Kagey-Sobotka A, Hendley JO, Sorrentino J and Gwaltney JM (1988) Kinins are generated during experimental rhinovirus colds. J Infect Dis 157:133-142.
150. Nadar R, Derrick A, Naidoo S, Naidoo Y, Hess F and Bhoola K (1996) Immunoreac- tive Bl receptors in human transbronchial tissue. Immunopharmacology 33:317-320.
151. 2 receptors of vasodepressor responses to intravenously administered kinins in anaesthetized dogs. Br J Pharmacol 110:71-76.
152. Naruse K, McGehee DS and Oxford GS (1992) Differential responses to Ca-activated K channels to bradykinin in sensory neurons and F-11 cells. Am J Physiol 262: C453-C460.
153. 1 receptor gene in inflammation. J Biol Chem (Tokyo) 273:2784-2791.
154. 1 hypotensive receptors in rats by lipopolysaccharide. Can J Physiol Pharmacol 74:337-340.
155. Nolly H, Carretero OA and Scicli AG (1993) Kallikrein release by vascular tissue. Am J Physiol 265:H1209-H1214.
156. 9]-bradykinin in low-renin essential hypertension before and after treatment with enalapril (MK-421). J Lab Clin Med 102:714-721.
157. Oza NB, Schwartz JH, Goud HD and Levinsky NG (1990) Rat aortic smooth muscle cells in culture express kallikrein, kininogen, and bradykininase activity. J Clin Invest 85:597-600.
158. 8]-BK and Hoe 140, in two models of persistent hyperalgesia in the rat Pain 53:191-197.
159. 1 receptors in vivo in a model of ultra-violet irradiation-induced thermal hyperalgesia in the rat. Br J Pharmacol 110:1441-1444.
160. Pesquero JB, Pesquero JL, Oliveira SM, Roscher AA, Metzger R, Ganten D and Bader M (1996) Molecular cloning and functional characterization of a mouse bradykinin Bl receptor gene. Biochem Biophys Res Comm 220:219-225.
161. Petitclerc E, Abel S, Deblois D, Poubelle PE and Marceau F (1992) Effects of interleukin-1 receptor antagonist on three types of responses to interleukin-1 in rabbit isolated blood vessels. J Cardiovasc Pharmacol 19:821-829.
162. Petitclerc E, Poubelle PE and Marceau F (1994) Rapid protein synthesis and turn-over is involved in interleukin-1-induced relaxation of the rabbit isolated mesenteric artery: Analysis of the arachidonate cascade. J Pharmacol Exp Ther 268: 1419-1425.
163. Phillips JA and Hoult S Jr (1988) Secretory effects of kinins on colonie epithelium in relation to prostaglandins released from cells of the lamina propria. Br J Pharmacol 95:701-712.
164. Powell SJ, Slynn G, Thomas C, Hopkins B, Briggs I and Graham A (1993) Human bradykinin B2 receptor: Nucleotide sequence analysis and assignment to chromosome 14. Genomics 15:435-438.
165. Prado GN, Taylor L and Polgar P (1997) Effects of intracellular tyrosine residue mutation and carboxyl terminus truncation on signal transduction and internalization of the rat bradykinin B2 receptor. J Biol Chem 272:14638-14642.
166. Proud D, Baumgarten CR, Nacleiro RM and Ward PE (1987) Kinin metabolism in human nasal secretions during experimentally induced allergic rhinitis. J Immunol 138:428-434.
167. Proud D, Togias A, Naclerio RN, Crush SA, Norman PS and Lichtenstein LM (1983) Kinins are generated in vivo following nasal airway challenge of allergic individuals with allergens. J Clin Invest 72:1678-1685.
168. 1 receptor-mediated relaxation in the isolated rabbit carotid artery. Ear J Pharmacol 239:63-67.
169. Pruneau D, Luccarini JM, Defrene E, Paquet JL and Bélichard P (1996) Characterization of bradykinin receptors from juvenile pig coronary artery. Eur J Pharmacol 297:53-60.
170. 1 receptor-dependent vasoconstriction following balloon catheter injury to the rabbit carotid artery. Br J Pharmacol 111:1029-1034.
171. Raidoo DM, Ramsaroop R, Naidoo S, Müller-Esterl W and Bhoola KD (1997) Kinin receptors in human vascular tissue: Their role in atheromatous disease. Immune-pharmacology 36:153-160.
172. 2 kinin receptors in the modulation of T-kininogen during the acute phase response of inflammation. Peptides 17:1163-1170.
173. 9-bradykinin using a chemiluminescence enzyme immunoassay: Application to its kinetic during plasma activation. J Immunol Methods 180:247-257.
174. Regoli D and Barabé J (1980) Pharmacology of bradykinin and related kinins. Pharmacol Rev 32:1-46.
175. Regoli D, Barabé J and Park WK (1977) Receptors for bradykinin in rabbit aortae. Can J Physiol Pharmacol 55:855-867.
176. 1-receptors for kinins in the rabbit by a bacterial lipopolysaccharide. Eur J Pharmacol 71:105-115.
177. Regoli D, Pheng LH, Allogho SN, Nguyen-Le XK and Gobeil F (1996) Receptors for kinins: From classical pharmacology to molecular biology. Immunopharmacology 33:24-31.
178. 2 receptor antagonism after focal cerebral ischaemia in the rat. Br J Pharmacol 120:76P.
179. 1 receptors. Life Sci 51: PL125-PL129.
180. Ribuot C, Godin D, Couture R, Regoli D and Nadeau R (1993) In vivo B2-receptor-mediated negative chronotropic effect of bradykinin in canine sinus node. Am J Physiol 265:H876-H879.
181. 2 receptors in pig vessels: Characterization of two monoreceptor systems, Naunyn-Schmiedeberg's Arch Pharmacol 356:662-670.
182. 1 receptor in the non-inflamed and inflamed rat urinary bladder. Br J Pharmacol 114:228P.
183. Rueff A, Dawson AJ and Mendell LM (1996) Characterization of nerve growth factor induced hyperalgesia in adult rats: Dependence on enhanced bradykinin-1 receptor activity but not neurokinin-1 receptor activation. Pain 66:359-372.
184. 2 receptor on nociception in rats and mice. Pain 71:89-97.
185. Ryan JW, Berryer P, Chung AYK and Sheffy DH (1994) Characterization of rat pulmonary vascular aminopeptidase P in vivo: Role in the inactivation of bradykinin. J Pharmacol Exp Ther 269:941-947.
186. 1 receptors in human umbilical vein. Eur J Pharmacol 321:33-38.
187. 2 receptor antagonist Proc Natl Acad Sci USA 91:4693-4697.
188. Sawutz DG, Singh SS, Tiberio L, Koszewski E, Johnson CG and Johnson CL (1992) The effect of TNF on bradykinin receptor binding, phosphatidylinositol turnover and cell growth in human A431 epidennoid carcinoma cell Immunopharmacology 24:1-10.
189. Schedlich LJ, Bennetts BH and Morris BJ (1987) Primary structure of a human glandular kallikrein gena DNA (N Y) 6:429-437.
190. Schild HO (1973) Receptor classification with special reference to beta-adrenergic receptors, in Drug Receptors (Rang HP ed) pp 29-36, University Park Press, Baltimore.
191. 3]-bradykinin in human plasma with post-source-decay matrix-assisted laser desorption/ionization mass spectrometry. Anal Biochem 246:15-19.
192. 2 receptor expression through mRNA stabilization and gene transcription in human bronchial smooth muscle cells. Br J Pharmacol 122:418P.
193. 1 receptors in rabbit aorta smooth muscle cells in culture. Eur J Pharmacol 266: 277-282.
194. Schremmer-Danninger E, Offner A, Siebeck M, Heinz-Erian P, Gais P and Roscher AA (1996) Autoradiographic visualization of Bl bradykinin receptors in porcine vascular tissue in the presence or absence of inflammation. Immunopharmacology 33:95-100.
195. 2 receptor knockout mice. Neuropharmacology 36:1009-1017.
196. Sejbal J, Wang Y, Cann JR, Stewart JM, Gera Land Kotovych G (1997) A comparative NMR and molecular dynamics study of the conformations of bradykinin Bl and B2 and Bl-specific receptors antagonists B-9430, B-9436 and B-9858. Biopolymers 42:521-535.
197. Sheikh LA and Kaplan AP (1989) Mechanism of digestion of bradykinin and lysylbradykinin (kallidin) in human serum: Roles of carboxypeptidase, angiotensinconverting enzyme and determination of final degradation products. Biochem Pharmacol 38:993-1000.
198. Shipp MA, Richardson NE, Sayre PH, Brown NR, Masteller EL, Clayton LK, Ritz J and Reinherz EL (1988) Molecular cloning of the common acute lymphoblastic leukemia antigen (CALLA) identifies a type II integral membrane protein Proc Natl Acad Sci USA 85:4819-4823.
199. Shipp MA, Vijayaraghavan J, Schmidt EV, Masteller EL, D'Adamio L, Hersh LB and Reinherz EL (1989) Common acute lymphoblastic leukemia antigen (CALLA) is active neutral endopeptidase 24.11 ("enkephalinase"): Direct evidence by cDNA transfection analysis. Proc Natl Acad Sci USA 86:297-301.
200. 1 receptor agonist studies in porcine endotoxin shock. Br J Pharmacol 120:l82P.
201. 2 kinin receptor blockade in porcine endotoxin shock, Immunopharmacology 33:81-84.
202. 9-bradykinin increases during E. coli septicemia in the pig. Adu Exp Med Biol 247B:389-393.
203. Skidgel RA, Davis RM and Tan F (1989) Human carboxypeptidase M. Purification and characterization of a membrane-bound carboxypeptidase that cleaves peptide hormones. J Biol Chem 264:2236-2241.
204. 2 bradykinin receptors in bovine pulmonary artery endothelial cells. Mol Pharmacol 47:525-534.
205. Soubrier F, Alhenc-Gelas F, Hubert C, Allegnru J, John M, Tregear G and Corvol P (1988) Two putative active centers in human angiotensin I-converting enzyme revealed by molecular cloning. Proc Natl Acad Sci USA 85:9386-9390.
206. Steranka LR, Manning DC, Dehaas CJ, Ferkany JW, Borosky SA, Connor JR, Vavrek RJ, Stewart JM and Snyder SH (1988) Bradykinin as a pain mediator: Receptors are localized to sensory neurons and antagonists have analgesic actions. Proc Natl Acad Sci USA 85:3245-3249.
207. Stewart JM (1995) Bradykinin antagonists: Development and applications. Biopolymers 37:143-155.
208. Stewart JM, Gera L, Hansen W, Zuzak JS, Burkard M, McCullough R and Whalley ET (1996) A new generation of bradykinin antagonists. Immunopharmacology 31:51-60.
209. Sufka KJ and Roach JT (1996) Stimulus properties and antinociceptive effects of selective bradykinin Bl and B2 receptor antagonists in the rat Pain 66: 99-103.
210. Takano M, Kondo J, Yayama K, Otani M, Sano K and Okamoto H (1997) Molecular cloning of cDNAs for mouse low-molecular-weight and high-molecular-weight prekininogens. Biochim Biophys Acta 1352:222-230.
211. Takeuchi K, Shimizu T, Oh-Ishi N, Seyama Y, Takaku F and Yotsumoto H (1989) Purification of human lung angiotensin-converting enzyme by high-performance liquid chromatography: Properties and N-terminal amino acid sequence. J Biochem (Tokyo) 106:442-445.
212. Tan F, Chan SJ, Steiner DF, Schilling JW and Skidgel RA (1989) Molecular cloning and sequencing of the cDNA for human membrane-bound carboxypeptidase M: Comparison with carboxypeptidases A, B, H, and N. J Biol Chem 264:13165-13170.
213. Tan F, Weerasinghe DK, Skidgel RA, Tamei H, Kaul RK, Roninson IB, Schilling JW and Erdös EG (1990) The deduced protein sequence of the human carboxypeptidase N high molecular weight subunit reveals the presence of leucine-rich tandem repeats. J Biol Chem 265:13-19.
214. 1 receptor agonists containing alkylic spacers, Bioorg Med Chem Lett 7:2661-2664.
215. 1 receptors in rat colonie epithelium. Br J Pharmacol 121:1005-1011.
216. Terashima H and Bunnett NW (1995) Purification and characterization of aminopeptidase M from muscle and mucosa of the pig intestine. J Gastroenterol 30:696-704.
217. 9-bradykinin in young Brown/Norway rats pretreated with endotoxin. Ear J Pharmacol 274:225-228.
218. 1 receptor-mediated nociception. Eur J Pharmacol 326:61-65.
219. Vavrek RJ and Stewart JM (1985) Competitive antagonists of bradykinin. Peptides 6:161-164.
220. 9-BK in mouse pleurisy. Br J Pharmacol 123:281-291.
221. Von Banchet GS, Petersen M and Heppelmann B (1996) Bradykinin receptors in cultured rat dorsal ganglion cells: Influence of length of time in culture, Neuroscience 75:1211-1218.
222. 2 receptor antagonists. Br J Pharmacol 117:684-688.
223. 1 receptor mRNA in the human kidney. Immunopharmacology 33:151-156.
224. Wang Q, Patton WF, Hechtman HB and Shepro D (1997) Activation of endothdial cell kinin receptors leads to intracellular calcium increases and filamin tranalocation: Regulation by protein kinase C. Cell Signalling 9:595-602.
225. Ward PE (1991) Metabolism of bradykinin and bradykinin analogs, in Bradykinin Antagonists (Burch RM ed) pp 147 Marcel Dekker, Inc., New York.
226. Whaliey ET, Clegg S, Stewart JM and Vavrek RJ (1987) The effect of kinin agonists and antagonists on the pain response-170. of the human blister base. Naunyn-Schmiedeberg Arch Pharmacol 336:652-655.
227. Whaliey ET, Sampaio CAM, Fritz H and Edwards G (1984) The effect of kinins on paw edema and uterus in rat Naunyn-Schmiedeberg's Arch Pharmacol 328:202-206.
228. Wu H, Venezie RD, Cohen WM, Jerizano JW, Featherstone GL and Lundblad RL (1993) Identification of tissue kallikrein mRNA in human neutrophils. Agents Actions 38:27-31.
229. Yang X and Polgar P (1996) Genomic structure of the human bradykinin B1 receptor gene and preliminary characterization of its regulatory regions. Biochem Biophys Res Comm. 222:718-725.
230. 1 receptor gene expression. Identification of a minimum cell-type specific enhancer. J Biol Chem 273: 10763-10770.
231. Yin T, Sandhu G, Wolfgang CD, Burner A, Webb RL, Rigel DF, Hai T and Whelan J (1997) Tissue-specific pattern of stress kinase activation in ischemic/reperfused heart and kidney. J Biol Chem 272:19943-19950.
232. Zhou GX, Chao L and Chao J (1992) Kallistatin: A novel human tissue kallikrein inhibitor-Purification, characterization and reactive center sequence. J Biol Chem 267:25873-25880.
233. 1 receptor gene expression, Biochem J 330:361-366.
234. Zolfaghari R, Little D, Baker CR, Canizaro PC and Behal FJ (1989) Human lung membrane-bound neutral-endopeptidase-catalyzed hydrolysis of bradykinin. Enzyme 42:160-173.
235. Zuccolo A, Cueva F, Frontera M, Navarro M and Catanzaro O (1996) The role of the kallikrein-kinin system in type I diabetes (insulitis). Immunopharmacology 33: 349-350.
236. 1 receptor. J Pharmacol Exp Ther 277:1337-1343.